Financiere de Tubize (XBRU:TUB) Common Stock : €235.00 Mil (As of Dec. 2023)

View and export this data going back to 1985. Start your Free Trial

What is Financiere de Tubize Common Stock?

Financiere de Tubize's quarterly common stock increased from Dec. 2022 (€235.00 Mil) to Jun. 2023 (€236.23 Mil) but then declined from Jun. 2023 (€236.23 Mil) to Dec. 2023 (€235.00 Mil).

Financiere de Tubize's annual common stock declined from Dec. 2021 (€236.23 Mil) to Dec. 2022 (€235.00 Mil) but then stayed the same from Dec. 2022 (€235.00 Mil) to Dec. 2023 (€235.00 Mil).

Financiere de Tubize Common Stock Historical Data

The historical data trend for Financiere de Tubize's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Financiere de Tubize Common Stock Chart

Financiere de Tubize Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

236.23

235.00

Financiere de Tubize Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Common Stock	Get a 7-Day Free Trial															236.23	236.23	235.00	236.23	235.00

Financiere de Tubize Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Financiere de Tubize (XBRU:TUB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Financiere de Tubize SA (XBRU:TUB) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

FTD:Germany

Address

Allée de la Recherche, 60, Brussels, BEL, 1070

Website

https://www.financiere-tubize.be

Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a global biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Most of its sales revenue is derived from its neurology products, followed by its immunology products. The company's strategy focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.

Financiere de Tubize (XBRU:TUB) Headlines

No Headlines